Y-mAbs Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of YMAB for the last quarter is 22.80 M USD, and it's 14.38% higher compared to the previous quarter. The net income of Q2 24 is -9.25 M USD.